State-of-the-art facilities adheri¥∑ng to cGMP standards, with designat ¥ &ed areas meeting ISO 7/Grade "♠★B+A and ISO 5/Grade C+A requiremen≥β↑ts for diverse process needs. Equippφ₽>ed with the latest instruments ←<€ for cell extraction, σπconcentration, culture, cry©Ωopreservation, and storage, support&£∑$ed by a robust quality management≠© system.
Our service team boasts ex♠§tensive expertise in pro≤ ♦cess development, scale-up, and la↕$rge-scale production, with §≈a deep understanding of the techn↔☆ologies required for the manufacturing ®£of cell-based therapies. The organizati®£onal structure is desigσ<✘ned to support the entire lifecy©∑cle of cell therapy product dev↔¶elopment.
Wu Ying
17821402110
wuying@ixcell.com.cn
